(S (S (PP-SBJ (NP (PP (BASENP (NN これら)) (IN の)) (NN 腎臓)) (IN は)) (VP (VP (PP (PP (NP (PP (NP (S-REL-NSBJ (VP (PP-OBJ (NP (PP (BASENP (NN 臓器) (NN 拒絶) (NN 反応)) (IN の)) (NN 問題)) (IN を)) (VP (VP (NN 回避) (VBV し)) (VP (MD た))))) (NN 患者)) (IN の)) (NN 組織)) (IN に)) (IN も)) (VBV なり)) (COMMA 、) (VP (PP-OBJ (NP (PP (NP (S-REL-NSBJ (VP (PP (NP (PP (BASENP (NN 人間)) (IN の)) (NN 移植)) (IN に)) (VP (NN 使用) (VB できる)))) (NN 腎臓)) (IN の)) (NN 蓄え)) (IN を)) (VB 増やす)))) (PERIOD 。))
これら の 腎臓 は 臓器 拒絶 反応 の 問題 を 回避 し た 患者 の 組織 に も なり 、 人間 の 移植 に 使用 できる 腎臓 の 蓄え を 増やす 。
These kidneys would also be of the patient 's tissue avoiding issues of organ rejection and would increase the pool of kidneys available for human transplant .